I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth? Επικοινωνία Submitted by Δημήτρης Σπάχος on Παρ, 12/04/2020 - 20:57
